Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Manitowoc
MTW
$497M
| $10.5M | ﹤0.01% |
426,725
+107
| +0% | +$2.55K |
|
|
EPAY
1977
DELISTED
Bottomline Technologies Inc
EPAY
| $10.4M | ﹤0.01% |
281,691
+4,557
| +2% | +$188K |
|
|
NARI
1978
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $10.4M | ﹤0.01% |
111,813
+38,167
| +52% | +$3.7M |
|
1979
Ichor Holdings
ICHR
$2.62B
| $10.4M | ﹤0.01% |
193,647
+3,731
| +2% | +$205K |
|
1980
Lemonade
LMND
$3.74B
| $10.4M | ﹤0.01% |
95,080
+2,810
| +3% | +$255K |
|
|
UMH
1981
UMH Properties
UMH
$1.29B
| $10.3M | ﹤0.01% |
473,958
+58,379
| +14% | +$1.24M |
|
|
CMRC
1982
Commerce.com Inc Series 1
CMRC
$258M
| $10.3M | ﹤0.01% |
159,231
+100,888
| +173% | +$5.71M |
|
1983
National Bank Holdings
NBHC
$1.92B
| $10.3M | ﹤0.01% |
273,843
+3,338
| +1% | +$132K |
|
1984
eHealth
EHTH
$42.2M
| $10.3M | ﹤0.01% |
176,828
-23
| -0% | -$1.51K |
|
1985
American Well
AMWL
$180M
| $10.3M | ﹤0.01% |
40,956
+21,703
| +113% | +$6.26M |
|
1986
Regenxbio
RGNX
$620M
| $10.3M | ﹤0.01% |
265,229
+19,407
| +8% | +$694K |
|
|
SNR
1987
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $10.3M | ﹤0.01% |
1,173,258
-207,089
| -15% | -$1.43M |
|
1988
Perdoceo Education
PRDO
$1.99B
| $10.3M | ﹤0.01% |
836,788
+27,908
| +3% | +$341K |
|
1989
Marten Transport
MRTN
$1.21B
| $10.2M | ﹤0.01% |
620,978
+37,292
| +6% | +$636K |
|
1990
Par Pacific Holdings
PARR
$4.31B
| $10.2M | ﹤0.01% |
607,971
+53,160
| +10% | +$799K |
|
1991
Axcelis
ACLS
$4.01B
| $10.2M | ﹤0.01% |
252,349
+3,021
| +1% | +$125K |
|
1992
RadNet
RDNT
$5.02B
| $10.2M | ﹤0.01% |
302,021
+9,228
| +3% | +$243K |
|
1993
Yext
YEXT
$547M
| $10.2M | ﹤0.01% |
711,069
+35,399
| +5% | +$493K |
|
|
DCPH
1994
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $10.1M | ﹤0.01% |
276,753
+6,369
| +2% | +$247K |
|
1995
Cytokinetics
CYTK
$10.5B
| $10.1M | ﹤0.01% |
511,304
+37,785
| +8% | +$887K |
|
1996
GoPro
GPRO
$130M
| $10.1M | ﹤0.01% |
867,318
+29,633
| +4% | +$334K |
|
|
CAI
1997
DELISTED
CAI International, Inc.
CAI
| $10.1M | ﹤0.01% |
179,836
-3,713
| -2% | -$165K |
|
1998
National Healthcare
NHC
$3.53B
| $10.1M | ﹤0.01% |
144,028
+9,440
| +7% | +$686K |
|
|
NBIS
1999
Nebius Group N.V.
NBIS
$48.3B
| $10M | ﹤0.01% |
141,989
+4,625
| +3% | +$303K |
|
|
ACCD
2000
DELISTED
Accolade Inc
ACCD
| $10M | ﹤0.01% |
184,755
+45,038
| +32% | +$2.19M |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.